派林生物
(000403)
| 流通市值：112.41亿 | | | 总市值：113.57亿 |
| 流通股本：9.41亿 | | | 总股本：9.50亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 435,528,823.24 | 770,157,845.79 | 575,902,080.71 | 559,086,605.74 |
| 交易性金融资产 | 263,710,458.99 | 254,385,624.02 | 658,872,185.55 | 477,097,058.24 |
| 应收票据及应收账款 | 894,841,729.26 | 993,236,448.42 | 697,206,926.28 | 630,115,456.37 |
| 其中：应收票据 | 51,970,751.15 | 63,652,615 | 52,761,932.53 | 53,598,738.36 |
| 应收账款 | 842,870,978.11 | 929,583,833.42 | 644,444,993.75 | 576,516,718.01 |
| 应收款项融资 | 71,766,670.94 | 95,813,656.31 | 71,236,676.16 | 18,784,578.91 |
| 预付款项 | 37,985,469.15 | 30,002,643.69 | 31,299,518.08 | 26,158,271.73 |
| 其他应收款合计 | 8,438,091.51 | 6,199,122.68 | 7,531,587.25 | 6,557,976.01 |
| 其中:应收利息 | 1,222,862.34 | 1,627,397.26 | 1,471,566.99 | 1,331,506.85 |
| 存货 | 1,791,792,488.49 | 1,563,473,838.46 | 1,730,902,371.57 | 1,600,890,769.75 |
| 其他流动资产 | 46,155,919.49 | 7,739,008.61 | 2,048,939.5 | 2,004,808.94 |
| 流动资产合计 | 3,550,219,651.07 | 3,721,008,187.98 | 3,775,000,285.1 | 3,320,695,525.69 |
| 非流动资产: | | | | |
| 长期应收款 | 700,000,000 | 600,000,000 | 600,000,000 | 600,000,000 |
| 其他非流动金融资产 | - | - | 6,000,000 | 6,000,000 |
| 投资性房地产 | 269,154.47 | 276,274.43 | 283,394.39 | 290,514.35 |
| 固定资产 | 1,800,351,644.93 | 1,830,901,713.42 | 1,754,222,894.49 | 1,749,643,575.2 |
| 在建工程 | 231,945,598.59 | 225,989,115.26 | 292,777,215.22 | 284,157,362.98 |
| 使用权资产 | 14,195,758.99 | 15,275,418.19 | 16,355,077.56 | 17,559,236.02 |
| 无形资产 | 187,162,788.55 | 190,219,726.57 | 190,253,983.08 | 191,850,228.48 |
| 开发支出 | 190,125,957.45 | 178,059,750.53 | 177,594,909.78 | 149,183,307.11 |
| 商誉 | 2,536,010,097.28 | 2,536,010,097.28 | 2,614,611,614.12 | 2,614,611,614.12 |
| 长期待摊费用 | 51,505,294.01 | 51,841,247.63 | 45,430,279.47 | 46,782,017.82 |
| 递延所得税资产 | 27,276,221.67 | 26,581,647.02 | 33,062,785.09 | 29,336,175.33 |
| 其他非流动资产 | 93,655,039.28 | 90,185,897.89 | 69,598,803.32 | 71,186,565.59 |
| 非流动资产合计 | 5,832,497,555.22 | 5,745,340,888.22 | 5,800,190,956.52 | 5,760,600,597 |
| 资产总计 | 9,382,717,206.29 | 9,466,349,076.2 | 9,575,191,241.62 | 9,081,296,122.69 |
| 流动负债: | | | | |
| 短期借款 | 536,310,337.48 | 535,704,305.56 | 758,641,928.53 | 396,933,638.24 |
| 应付票据及应付账款 | 133,710,869.43 | 155,259,545.5 | 127,189,607.67 | 137,928,789.39 |
| 其中：应付票据 | - | 3,984,757.6 | 3,984,757.6 | 15,839,722.56 |
| 应付账款 | 133,710,869.43 | 151,274,787.9 | 123,204,850.07 | 122,089,066.83 |
| 合同负债 | 3,690,882.36 | 3,043,419.73 | 3,146,670.21 | 3,895,339.8 |
| 应付职工薪酬 | 35,326,806.86 | 71,291,944.33 | 28,762,087.78 | 33,896,334.6 |
| 应交税费 | 36,169,463.41 | 43,306,950.65 | 43,229,881.87 | 40,011,245.96 |
| 其他应付款合计 | 216,518,549.88 | 229,424,012.49 | 248,894,839.92 | 230,977,137.46 |
| 应付股利 | 1,093,534.43 | 1,093,534.43 | 1,369,085.97 | 2,156,191.37 |
| 一年内到期的非流动负债 | 75,132,243.64 | 71,590,753.94 | 63,439,725.52 | 41,200,255.56 |
| 其他流动负债 | 15,787,935.61 | 18,862,471.82 | 13,265,797.75 | 19,194,761.45 |
| 流动负债合计 | 1,052,647,088.67 | 1,128,483,404.02 | 1,286,570,539.25 | 904,037,502.46 |
| 非流动负债: | | | | |
| 长期借款 | 161,848,541.66 | 193,828,468.4 | 197,264,291.71 | 217,886,435.89 |
| 租赁负债 | 13,802,205.1 | 11,939,656.66 | 12,689,612.64 | 12,966,267.92 |
| 长期应付款 | - | - | 9,000,000 | 9,000,000 |
| 预计负债 | - | - | 631,587 | 647,107 |
| 递延收益 | 37,483,900.29 | 36,973,979.73 | 37,078,996.66 | 25,995,961.97 |
| 递延所得税负债 | 12,964,962.12 | 13,874,638.62 | 12,789,409.5 | 13,222,124.21 |
| 非流动负债合计 | 226,099,609.17 | 256,616,743.41 | 269,453,897.51 | 279,717,896.99 |
| 负债合计 | 1,278,746,697.84 | 1,385,100,147.43 | 1,556,024,436.76 | 1,183,755,399.45 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 950,397,386 | 950,397,386 | 950,397,386 | 950,397,386 |
| 资本公积 | 4,538,892,789.16 | 4,538,892,789.16 | 4,538,892,789.16 | 4,538,892,789.16 |
| 其他综合收益 | 30,865.02 | 40,832.74 | 47,320.95 | 51,734.56 |
| 盈余公积 | 177,313,391.27 | 177,313,391.27 | 162,791,551.76 | 161,574,403.37 |
| 未分配利润 | 2,444,351,904.6 | 2,421,383,071.4 | 2,373,819,669.32 | 2,253,648,584.8 |
| 归属于母公司股东权益合计 | 8,110,986,336.05 | 8,088,027,470.57 | 8,025,948,717.19 | 7,904,564,897.89 |
| 少数股东权益 | -7,015,827.6 | -6,778,541.8 | -6,781,912.33 | -7,024,174.65 |
| 股东权益合计 | 8,103,970,508.45 | 8,081,248,928.77 | 8,019,166,804.86 | 7,897,540,723.24 |
| 负债和股东权益合计 | 9,382,717,206.29 | 9,466,349,076.2 | 9,575,191,241.62 | 9,081,296,122.69 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-29 | 2025-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |